FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

746311000168101: betamethasone acetate 3 mg / 1 mL + betamethasone sodium phosphate 3.9 mg / 1 mL injection, 1 mL ampoule (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1511051000168117 betamethasone acetate 3 mg / 1 mL + betamethasone sodium phosphate 3.9 mg / 1 mL injection, 1 mL ampoule (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1511061000168115 betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule Is a betamethasone acetate + betamethasone sodium phosphate true Inferred relationship Some
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule Is a medicinal product unit of use true Inferred relationship Some
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule has manufactured dose form injection true Inferred relationship Some
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule has unit of use ampoule true Inferred relationship Some 1937692747
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule has Australian BoSS betamethasone sodium phosphate true Inferred relationship Some 1937692746
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule has intended active ingredient betamethasone sodium phosphate true Inferred relationship Some 1937692746
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule has Australian BoSS betamethasone acetate true Inferred relationship Some 1302647798
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule has intended active ingredient betamethasone acetate true Inferred relationship Some 1302647798
Inbound Relationships Type Active Source Characteristic Refinability Group
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules has MPUU True betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule Inferred relationship Some 1
Celestone Chronodose injection, ampoule Is a True betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule Inferred relationship Some
betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 2 x 1 mL ampoules has MPUU True betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule Inferred relationship Some 1

Reference Sets

Australian dialect reference set

Medicinal product unit of use reference set

Back to Start